PharmaShots | Incisive News in 3 Shots

Subscribe Now

dMMR Recurrent or Advanced Solid Tumors

GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Accelerated Approval for the Treatment of dMMR Recurrent or Advanced Solid Tumors

GSK's Jemperli (dostarlimab-gxly) Receives the US FDA's Accelerated Approval for the Treatment of dMMR Recurrent or Advanced Solid...

August 18, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us